Directori de persones
Maria Cristina Marzo Alonso

Maria Cristina Marzo Alonso

Grau: Llicenciat/da


mcmarzo.lleida.ics(ELIMINAR)@gencat.cat

Grups

Publicacions

  • Mingot, CG; Lasaosa, SS; Campas, LC; Canaval, LC; Sánchez, AG; Ruiz, LB; Alonso, MCM; Moncusi, SP; Marsal, JV; Carner, SC; García, FP

    Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study

    SCIENTIFIC REPORTS 13 19416-19416. .

    [doi:10.1038/s41598-023-44522-8]

  • Jimenez-Yuste, V; Alvarez-Roman, MT; Bravo, AP; Galmes, BJ; Hernandez, MDN; Hidalgo, OB; Alonso, CM; Gonzalez, NFP; Coll, J; Nunez, R; Carrasco, M; Candel, FG; Gonzalez-Porras, JR; Garcia, CH; Castro, MJV; Mir, R

    Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study

    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS 28 -. .

    [doi:10.1177/10760296221074348]

  • Gavín O; Grandes J; García MA; Marzo C; Curcio A; Arístegui R; González M; Cerezo-Manchado JJ

    Treatment preferences as basis for decision making in patients using direct oral anticoagulants in Spain.

    Journal Of Thrombosis And Thrombolysis 51 475-484. .

    [doi:10.1007/s11239-020-02194-5]

  • Colàs-Campàs L; Royo, JL; Montserrat, MV; Marzo, C; Molina-Seguin, J; Benabdelhak, I; Cambray, S; Purroy, F

    The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation

    PHARMACOGENOMICS JOURNAL 18 652-656. .

    [doi:10.1038/s41397-017-0007-z]

  • Olivera, P; Gabilondo, M; Constans, M; Tàssies D; Plensa, E; Pons, V; Las Heras G; Jimenez, C; Campoy, D; Bustins, A; Oliver, A; Marzo, C; Canals, T; Varela, A; Sorigue, M; Sanchez, E; Ene, G; Perea, G; Vicente, L; Lopez, M; Cerda, M; Johansson, E; Aguinaco, MR; Santos, N; Mateo, J; Reverter, JC; Moya, A; Santamaria, A

    Recommendations of the Catalan Group of Thrombosis (Tromboc@t Working Group) for the treatment of patients receiving oral direct anticoagulants

    MEDICINA CLINICA 151 210-210. .

    [doi:10.1016/j.medcli.2018.01.022]

  • Rivera K; Marzo C; Sans N; Ferrero A; Aldomà A; Schoenenberger JA; Galván L; Worner F

    Consensus is Possible: Initiation and Exchange of Oral Anticoagulants in Non-valvular Atrial Fibrillation, According to a Territorial Protocol in a Period of Time.

    European Cardiology 12 104-104. .

    [doi:10.15420/ecr.2017:23:13]

  • Mas-Atance J; Marzo-Alonso C; Matute-Crespo M; Trujillano-Cabello JJ; Català-Tello N; de Miguel-Artal M; Fernández-Martínez JJ

    Estudio comparativo aleatorizado de la intervención quirúrgica temprana frente a la demorada en los pacientes con fractura de cadera tratados con antiagregantes plaquetarios. Determinación de la agregabilidad plaquetaria y el sangrado perioperatorio, y la revisión de la mortalidad al año.

    Revista Española De Cirugía Ortopédica Y Traumatología 57 240-253. .

    [doi:10.1016/j.recot.2011.12.007]

  • Catala Tella, N.; Araguas Arasanz, C.; Marzo Alonso, C.

    Severe haemophilia. a case of an infant aged 5 months

    ANALES DE PEDIATRIA 72 363-364. .

    [doi:10.1016/j.anpedi.2010.01.003]

Projectes

  • ESTUDIO COMPARATIVO FRACTURAS OSTEOPOROTICAS DE CADERA DE PAC. TRATADOS CON ANTIAGREGANTES PLAQUETARIOS RESPECTO AL TIEMPO DE DEMORA QUIRURGICO